(Q44591951)

English

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations (English)

1 reference

Europe PubMed Central

4 December 2017

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations (English)

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

membrane glycoprotein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

nerve tissue protein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Wolfgang H. Oertel

2

object named as

Wolfgang H Oertel

1 reference

Europe PubMed Central

4 December 2017

Oliver Pogarell

5

object named as

Oliver Pogarell

1 reference

Europe PubMed Central

4 December 2017

author name string

Jim Patterson

3

1 reference

Europe PubMed Central

4 December 2017

Hani T. S. Benamer

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

Donald M. Hadley

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

H. Höffken

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

A. Gerstner

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

Donald G. Grosset

8

0000-0002-2757-8203

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502664

12 March 2024

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.10482

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

https://onlinelibrary.wiley.com/doi/full/10.1002/mds.10482

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Movement Disorders

1 reference

Europe PubMed Central

4 December 2017

18

1 reference

Europe PubMed Central

4 December 2017

9

1 reference

Europe PubMed Central

4 December 2017

977-984

1 reference

Europe PubMed Central

4 December 2017

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

1

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Subtle extrapyramidal signs can predict the development of dementia in elderly individuals

3

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

4

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Accuracy of diagnosis in patients with presumed Parkinson's disease

5

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Ageing and Parkinson's disease: substantia nigra regional selectivity

6

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

7

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

8

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

10

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

11

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus

12

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

13

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

16

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

18

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Irreversible motor impairment in young addicts--ephedrone, manganism or both?

20

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Parkinsonism: onset, progression, and mortality

21

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Apomorphine test for dopaminergic responsiveness

23

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

24

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease

25

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Updated guidelines for the management of Parkinson's disease

26

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

28

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism

30

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?

31

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy

32

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

33

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

34

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Multiple system atrophy: a review of 203 pathologically proven cases

35

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

36

1 reference

10.1002/MDS.10482

https://api.crossref.org/works/10.1002/MDS.10482

12 March 2024

Identifiers

10.1002/MDS.10482

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44591951&oldid=2100479562"